about
Cognitive decline with nortriptyline use in a patient with dementia of the Alzheimer's typeDepression and dementia: comorbidities, identification, and treatment.Incidence and Course of Depression in Patients with Alzheimer's Disease.North of England evidence based guidelines development project: guideline for the primary care management of dementiaDepressive syndromes in dementia.Managing the care of patients with dementia. How to maximize level of functioning and minimize behavior problems.Quantifying the accretion of hyperphosphorylated tau in the locus coeruleus and dorsal raphe nucleus: the pathological building blocks of early Alzheimer's disease.Cognition activators.A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia.Depression in Alzheimer's disease: receiver operating characteristic analysis of the Cornell Scale for Depression in Dementia and the Hamilton Depression Scale.Troublesome and disruptive behaviors in dementia. Relationships to diagnosis and disease severity.The clock drawing test as a measure of executive dysfunction in elderly depressed patients.Clinical characteristics of community-dwelling black Alzheimer's disease patients.Affective disturbances in Alzheimer's disease.State-dependent nature of the clock drawing task in geriatric depression.Treatment of depression in advanced Alzheimer's disease using sertraline.Intractable depression and pseudodementia: a report of two cases.Predictors of depressive symptoms in persons with Alzheimer's disease.Depressive symptoms increase the likelihood of cognitive impairment in elderly people with subclinical Alzheimer pathology.Validating the GDS depression screen in the nursing home.Depressive disorders in Chinese patients with Alzheimer's disease.Functional status and cognitive impairment in Alzheimer's patients with and without depression.The evaluation of behavioral disturbances in Alzheimer's disease: the utility of three rating scales.The neuropathology of aminergic nuclei in Alzheimer's disease.Prevalence of depression in Alzheimer's disease and validity of Research Diagnostic Criteria.
P2860
Q28324503-25F7D46B-2486-4049-A939-EF3562686BCBQ33609585-15F9C03C-8901-489C-83C1-00244A500997Q33715026-C62BFD1F-A700-44D2-B68F-ED74E1879853Q33791951-315D74A4-F7B7-4A6F-BF3C-2212B192A49EQ34174245-AAB7D514-910E-4ADD-A6C8-26596FA5955CQ37298060-A64BE429-119D-405D-AE66-8AF32170BA05Q39002052-9B972563-3B97-48CE-9D5F-FA94C1F5989BQ39515095-4B0DE1ED-39D6-4F46-A893-09C96AA5A5ACQ43632183-1700256E-4EAC-4ED9-BC85-EB9DE4ACB924Q43645066-F46125E4-36B6-4104-B98A-7128D8EE440DQ43976470-FF86A207-EC53-4CA4-BE61-D3E5F230E484Q46127579-8D9A5AEF-7A19-4FA8-9938-61CD180057FAQ46956650-46E8C0D9-2D79-4226-9DA9-2432DCBB5512Q51111572-DB3C2ABD-81C4-4C32-82E7-DA0E839F0AA2Q51123422-280CFC97-DA22-452F-A7D6-4F57F3F315C3Q51130998-B502566B-095B-4CD2-8997-690D427A2D7DQ51185324-7743F06B-2330-4FB4-90F6-8ED103290E56Q51942544-D5D5106E-713F-49D0-AEAD-7730D89583E8Q51988885-55C8585C-3BF1-4E4C-9374-56248B04D738Q52026406-5EFDB7EF-4067-4DDF-9FC0-477913DBFBDFQ52029983-237F2625-3CF3-4D95-A56A-7643CE73BC9FQ52061892-462D9AF8-C302-454C-B897-739DAA7E6A32Q52884005-206135D4-E35C-4220-B533-A33A71D71209Q53191668-8D413B86-C078-46E9-8D6E-DCFD88D9EBAAQ53203299-4B9D3843-9465-4127-8D32-FB3C2BD8DCA1
P2860
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Dementia of the Alzheimer's type and depression.
@en
Dementia of the Alzheimer's type and depression.
@nl
type
label
Dementia of the Alzheimer's type and depression.
@en
Dementia of the Alzheimer's type and depression.
@nl
prefLabel
Dementia of the Alzheimer's type and depression.
@en
Dementia of the Alzheimer's type and depression.
@nl
P2093
P2860
P1476
Dementia of the Alzheimer's type and depression.
@en
P2093
P2860
P304
P356
10.1111/J.1532-5415.1986.TB07258.X
P407
P577
1986-12-01T00:00:00Z